ANKRD7
gene geneOn this page
Also known as TSA806
Summary
ANKRD7 (ankyrin repeat domain 7, HGNC:18588) is a protein-coding gene on chromosome 7q31.31, encoding Ankyrin repeat domain-containing protein 7 (Q92527).
Predicted to act upstream of or within blastocyst hatching. Located in centrosome and nucleoplasm.
Source: NCBI Gene 56311 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 41 total — 1 likely-pathogenic
- MANE Select transcript:
NM_019644
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18588 |
| Approved symbol | ANKRD7 |
| Name | ankyrin repeat domain 7 |
| Location | 7q31.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TSA806 |
| Ensembl gene | ENSG00000106013 |
| Ensembl biotype | protein_coding |
| OMIM | 610731 |
| Entrez | 56311 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 4 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000265224, ENST00000417525, ENST00000433239, ENST00000477532, ENST00000486422, ENST00000490445, ENST00000634332
RefSeq mRNA: 1 — MANE Select: NM_019644
NM_019644
CCDS: CCDS43638
Canonical transcript exons
ENST00000265224 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000881953 | 118239909 | 118239998 |
| ENSE00001818380 | 118224704 | 118225009 |
| ENSE00001855056 | 118242349 | 118242732 |
| ENSE00003474054 | 118236790 | 118236926 |
| ENSE00003540659 | 118236041 | 118236147 |
| ENSE00003626840 | 118234701 | 118234874 |
| ENSE00003636293 | 118234431 | 118234545 |
Expression profiles
Bgee: expression breadth ubiquitous, 169 present calls, max score 99.65.
FANTOM5 (CAGE): breadth broad, TPM avg 2.6516 / max 1703.7480, expressed in 494 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 80736 | 1.5898 | 4 |
| 80735 | 1.0405 | 493 |
| 80737 | 0.0174 | 3 |
| 80738 | 0.0038 | 2 |
Top tissues by expression
285 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| left testis | UBERON:0004533 | 99.65 | gold quality |
| right testis | UBERON:0004534 | 99.60 | gold quality |
| adult organism | UBERON:0007023 | 99.05 | gold quality |
| sperm | CL:0000019 | 98.18 | gold quality |
| male germ cell | CL:0000015 | 98.12 | gold quality |
| testis | UBERON:0000473 | 97.08 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.63 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 85.51 | gold quality |
| secondary oocyte | CL:0000655 | 81.98 | gold quality |
| adrenal tissue | UBERON:0018303 | 74.90 | gold quality |
| islet of Langerhans | UBERON:0000006 | 67.40 | gold quality |
| metanephros cortex | UBERON:0010533 | 64.02 | gold quality |
| body of pancreas | UBERON:0001150 | 62.66 | gold quality |
| pancreas | UBERON:0001264 | 62.65 | gold quality |
| right coronary artery | UBERON:0001625 | 62.12 | gold quality |
| left adrenal gland | UBERON:0001234 | 61.27 | gold quality |
| oocyte | CL:0000023 | 61.05 | gold quality |
| adenohypophysis | UBERON:0002196 | 60.92 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 60.69 | gold quality |
| right adrenal gland | UBERON:0001233 | 60.31 | gold quality |
| adrenal gland | UBERON:0002369 | 60.03 | gold quality |
| prefrontal cortex | UBERON:0000451 | 59.20 | gold quality |
| pituitary gland | UBERON:0000007 | 58.89 | gold quality |
| adrenal cortex | UBERON:0001235 | 58.87 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 58.72 | gold quality |
| right atrium auricular region | UBERON:0006631 | 58.48 | gold quality |
| cardiac atrium | UBERON:0002081 | 57.75 | gold quality |
| cortex of kidney | UBERON:0001225 | 57.56 | gold quality |
| cortical plate | UBERON:0005343 | 57.42 | gold quality |
| calcaneal tendon | UBERON:0003701 | 57.32 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 6774.60 |
| E-GEOD-124263 | yes | 3173.35 |
| E-ANND-3 | yes | 4.85 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- evidence suggests that ANKRD7 and CYTL1 genes may play an important role in the variance in alcohol drinking risk (PMID:22613542)
Cross-species orthologs
0 orthologs
Paralogs (1): MTPN (ENSG00000105887)
Protein
Protein identifiers
Ankyrin repeat domain-containing protein 7 — Q92527 (reviewed: Q92527)
Alternative names: Testis-specific protein TSA806
All UniProt accessions (5): Q92527, A0A0U1RQQ7, A0A140VJE5, C9J2M7, C9JIJ7
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Testis specific.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q92527-1 | 1 | yes |
| Q92527-2 | 2 |
RefSeq proteins (1): NP_062618* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR050657 |
Pfam: PF12796
UniProt features (8 total): repeat 5, chain 1, splice variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q92527-F1 | 83.97 | 0.62 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 60 (showing top):
MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER, GNF2_CCNA1, chr7q31, MODULE_220, KOYAMA_SEMA3B_TARGETS_DN, IL21_UP.V1_UP, HMGA1_TARGET_GENES, ZNF33A_TARGET_GENES, ZSCAN31_TARGET_GENES, MIR545_3P, MIR670_3P, MIR6740_3P, MIR5001_3P, MIR3674, MIR141_5P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): nucleoplasm (GO:0005654), centrosome (GO:0005813)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| centriole | 1 |
| microtubule organizing center | 1 |
Protein interactions and networks
STRING
1126 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ANKRD7 | CFAP99 | D6REC4 | 527 |
| ANKRD7 | TSACC | Q96A04 | 448 |
| ANKRD7 | CCDC24 | Q8N4L8 | 431 |
| ANKRD7 | CCDC54 | Q8NEL0 | 424 |
| ANKRD7 | C11orf71 | Q6IPW1 | 397 |
| ANKRD7 | C22orf23 | Q9BZE7 | 390 |
| ANKRD7 | ZFP14 | Q9HCL3 | 382 |
| ANKRD7 | FSCB | Q5H9T9 | 378 |
| ANKRD7 | TRIM61 | Q5EBN2 | 377 |
| ANKRD7 | SMIM14 | Q96QK8 | 376 |
| ANKRD7 | CATSPERT | Q53TS8 | 375 |
| ANKRD7 | NUP210L | Q5VU65 | 371 |
| ANKRD7 | TMCO5A | Q8N6Q1 | 371 |
| ANKRD7 | LIMS3 | P0CW19 | 370 |
| ANKRD7 | PPP4R4 | Q6NUP7 | 370 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ANKRD7 | psi-mi:“MI:0915”(physical association) | 0.370 | |
| ANKRD7 | HSPB1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| MARK3 | ANKRD7 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (2): ANKRD7 (Two-hybrid), ANKRD7 (Cross-Linking-MS (XL-MS))
ESM2 similar proteins: A0PJZ0, A6NHY2, A7E2S9, C7B178, D3J162, G5E8K5, P42570, P42773, P53355, Q08E43, Q10311, Q14DN9, Q18297, Q2T9W8, Q3EC11, Q4R3S3, Q4R544, Q4UJC4, Q4UJJ2, Q5EFR1, Q5I126, Q5I148, Q5I155, Q5I159, Q5I160, Q5R6D7, Q5RCK5, Q5TYM7, Q5VYY1, Q60772, Q60773, Q6XJU9, Q80YE7, Q86WC6, Q91ZT9, Q91ZU0, Q92527, Q9BGT9, Q9CQM6, Q9D119
Diamond homologs: A0A0A6YYL3, A0JP26, A0PJZ0, A2A2Z9, A2RUR9, A5A3E0, A6NC57, A6NI47, A7E2S9, B2RU33, H3BUK9, P0CG38, P0CG39, Q3MJ40, Q4R3S3, Q4UJ75, Q5CZ79, Q5JPF3, Q5SQ80, Q5TYW2, Q5VUR7, Q6NSI1, Q6S545, Q6S5H5, Q6S8J3, Q6S8J7, Q811D2, Q86YR6, Q8IYA2, Q92527, Q9BXX2, Q9BXX3, Q9D504, Q9H560, Q9UPS8, Q8IVF6, A6QL64, Q8N2N9, Q8NF67, Q96IX9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
41 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 34 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 563410 | GRCh37/hg19 7q31.2-31.31(chr7:115520087-118098306)x1 | Likely pathogenic |
SpliceAI
1084 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:118234421:A:AG | acceptor_gain | 1.0000 |
| 7:118234421:ATT:A | acceptor_gain | 1.0000 |
| 7:118234422:T:G | acceptor_gain | 1.0000 |
| 7:118234423:T:TA | acceptor_gain | 1.0000 |
| 7:118234427:A:AG | acceptor_gain | 1.0000 |
| 7:118234428:T:G | acceptor_gain | 1.0000 |
| 7:118234428:TA:T | acceptor_loss | 1.0000 |
| 7:118234429:A:AG | acceptor_gain | 1.0000 |
| 7:118234430:G:A | acceptor_loss | 1.0000 |
| 7:118234430:G:GA | acceptor_gain | 1.0000 |
| 7:118234430:GA:G | acceptor_gain | 1.0000 |
| 7:118234430:GAA:G | acceptor_gain | 1.0000 |
| 7:118234430:GAAC:G | acceptor_gain | 1.0000 |
| 7:118234430:GAACA:G | acceptor_gain | 1.0000 |
| 7:118234541:TTAAG:T | donor_loss | 1.0000 |
| 7:118234542:TAAG:T | donor_loss | 1.0000 |
| 7:118234543:AAGGT:A | donor_loss | 1.0000 |
| 7:118234544:AGG:A | donor_loss | 1.0000 |
| 7:118234546:G:GA | donor_loss | 1.0000 |
| 7:118234547:T:G | donor_loss | 1.0000 |
| 7:118236135:A:G | donor_gain | 1.0000 |
| 7:118239908:GATA:G | acceptor_gain | 1.0000 |
| 7:118234423:T:A | acceptor_loss | 0.9900 |
| 7:118234700:GGCA:G | acceptor_gain | 0.9900 |
| 7:118234870:ATAAG:A | donor_loss | 0.9900 |
| 7:118234871:TAAG:T | donor_loss | 0.9900 |
| 7:118234872:AAG:A | donor_loss | 0.9900 |
| 7:118234873:AG:A | donor_loss | 0.9900 |
| 7:118234874:GG:G | donor_loss | 0.9900 |
| 7:118234875:G:C | donor_loss | 0.9900 |
AlphaMissense
1680 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:118234701:G:C | A99P | 0.992 |
| 7:118234452:T:G | C67W | 0.989 |
| 7:118234516:G:C | D89H | 0.989 |
| 7:118234517:A:C | D89A | 0.987 |
| 7:118234450:T:C | C67R | 0.986 |
| 7:118234741:T:C | L112P | 0.986 |
| 7:118234517:A:T | D89V | 0.984 |
| 7:118236065:G:C | A165P | 0.984 |
| 7:118234871:T:A | N155K | 0.982 |
| 7:118234871:T:G | N155K | 0.982 |
| 7:118234484:T:C | L78P | 0.981 |
| 7:118234800:G:C | A132P | 0.981 |
| 7:118234770:G:C | D122H | 0.980 |
| 7:118234771:A:T | D122V | 0.980 |
| 7:118234451:G:A | C67Y | 0.978 |
| 7:118234518:T:A | D89E | 0.977 |
| 7:118234518:T:G | D89E | 0.977 |
| 7:118234837:T:C | L144P | 0.977 |
| 7:118236102:T:C | L177P | 0.977 |
| 7:118224928:C:A | A33D | 0.976 |
| 7:118234445:T:C | L65P | 0.975 |
| 7:118234447:G:C | A66P | 0.973 |
| 7:118234771:A:C | D122A | 0.972 |
| 7:118234538:T:C | L96S | 0.971 |
| 7:118224952:T:C | L41P | 0.970 |
| 7:118234738:T:C | L111P | 0.970 |
| 7:118234870:A:T | N155I | 0.970 |
| 7:118234738:T:A | L111H | 0.969 |
| 7:118234448:C:A | A66D | 0.968 |
| 7:118234516:G:T | D89Y | 0.968 |
dbSNP variants (sampled 300 via entrez): RS1000486239 (7:118239639 C>G,T), RS1000509277 (7:118233216 T>C), RS1000541889 (7:118233700 A>G), RS1000555736 (7:118240311 C>A,G,T), RS1000717410 (7:118233103 G>T), RS1001205679 (7:118226897 A>G), RS1001662508 (7:118234147 G>A), RS1001776565 (7:118240528 A>T), RS1001902641 (7:118234380 T>C), RS1001976658 (7:118240347 A>G), RS1002005719 (7:118239040 G>A,C,T), RS1002129347 (7:118225357 G>A), RS1002154389 (7:118231985 G>A), RS1002279101 (7:118238574 A>G), RS1002509092 (7:118229204 T>A)
Disease associations
OMIM: gene MIM:610731 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005024_61 | Pursuit maintenance gain | 9.000000e-06 |
| GCST006979_146 | Heel bone mineral density | 1.000000e-14 |
| GCST007831_1 | Anti-thyroglobulin (TgAb) levels in Hashimoto’s thyroiditis | 2.000000e-07 |
| GCST007851_2 | Anti-thyroid peroxidase (TPOAb) and anti-thyroglobulin (TgAb) levels in Hashimoto’s thyroiditis | 2.000000e-06 |
| GCST009439_21 | Age-related cognitive decline (language) (slope of z-scores) | 4.000000e-06 |
| GCST012489_138 | Heel bone mineral density x serum urate levels interaction | 2.000000e-08 |
EFO canonical traits (4, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008433 | pursuit maintenance gain measurement |
| EFO:0009270 | heel bone mineral density |
| EFO:0007710 | cognitive decline measurement |
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium Chloride | increases abundance, increases expression, decreases expression | 3 |
| Cadmium | decreases expression, increases abundance, increases expression | 2 |
| terbufos | increases methylation | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Fonofos | increases methylation | 1 |
| Endosulfan | increases expression | 1 |
| Lipopolysaccharides | affects response to substance, increases expression | 1 |
| Parathion | increases methylation | 1 |
| Silicon Dioxide | increases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.